Learn More
Carbosynth LLC. NAP Peptide, 5mg, CAS# 11439-12-2, MF= C36H60N10O12

Supplier: Carbosynth LLC. NAP3012PI5MG
This item has a minimum order quantity of 2 per supplier requirements
Davunetide; ADNP Neuropeptide Fragment; H-Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln-OH, Application: Short Neuropeptide Fragment Derived from Activity-Dependent Neuroprotective Protein (ADNP); May Have Neuroprotective Effects Against Schizophrenia-Related Impairment, Toxicity Associated with Beta-Amyloid and Other Compounds, Notes: NAP peptide is a short neuropeptide fragment derived from Activity-Dependent Neuroprotective Protein (ADNP). This octopeptide may have neuroprotective effects against schizophrenia-related impairment, toxicity associated with beta-amyloid and other compounds, stabilizing microtuble breakdown which may suggest therapeutic strategies for Parkinson's, Alzheimer's and related diseases., salt: Trifluoroacatate Salt, one letter code: NAPVSIPQ, MW: 824.94
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.